Existing calls welcome proposals to develop medical countermeasures against SARS-CoV-2/COVID-19
NIAID announces that a number of existing calls will particularly welcome research objectives related to pathogenicity, transmission, medical countermeasures, pre-clinical testing of vaccines and therapeutics.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.